FIELD: medicine. SUBSTANCE: effective dose of chimeric immunoglobulin or its fragment showing specificity to glycoprotein IIb/IIIa is prescribed to patient in order to inhibit stenosis and/or restenosis. Indicated immunoglobulin or its fragment has nonhuman antigen binding region and specific to glycoprotein IIb/IIIa and constant region of human immunoglobulin. EFFECT: decreased amount of allergic responses. 33 cl, 19 tbl, 15 dwg, 8 ex
Authors
Dates
2000-10-27—Published
1994-11-07—Filed